The designation will provide Lundbeck with the possibility of rolling reviews and detailed guidance to streamline the drug ...

Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated in neurodegenerative diseases like Parkinson's ...

Alzheimer's Disease Clinical Trial Pipeline Major pharmaceutical companies are working to advance the pipeline space and unlock the future ...

According to the Death Penalty Information Center, 25 people were executed in the United States in 2024. The number of death sentences imposed was 26. There are 2,092 people on death row in the United ...

SNS Insider Reports: Increasing Awareness, Advancements in Drug Development, and government Initiatives fuel market Growth at a CAGR of 4.06% from 2024-2032 ...